Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS)
CNY 30.73
(0.33%)
CNY 30.73
(0.33%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -557.74 Million CNY | 23.14% |
| 2022 | -725.67 Million CNY | 29.59% |
| 2021 | -1.03 Billion CNY | -1.52% |
| 2020 | -1.01 Billion CNY | -154.22% |
| 2019 | -399.36 Million CNY | -9.48% |
| 2018 | -364.78 Million CNY | -33.73% |
| 2017 | -272.76 Million CNY | -20.14% |
| 2016 | -227.03 Million CNY | -233.74% |
| 2015 | -68.02 Million CNY | -160.98% |
| 2014 | -26.06 Million CNY | -333.6% |
| 2013 | 11.15 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -420.96 Million CNY | -9.68% |
| 2024 Q1 | -620.01 Million CNY | -11.16% |
| 2024 Q2 | -383.82 Million CNY | 38.09% |
| 2023 Q2 | -509.49 Million CNY | -2.75% |
| 2023 FY | -557.74 Million CNY | 23.14% |
| 2023 Q3 | -360.21 Million CNY | 29.3% |
| 2023 Q1 | -495.86 Million CNY | 31.67% |
| 2023 Q4 | -557.74 Million CNY | -54.84% |
| 2022 Q2 | -314.92 Million CNY | 42.4% |
| 2022 Q1 | -546.78 Million CNY | 46.95% |
| 2022 FY | -725.67 Million CNY | 29.59% |
| 2022 Q4 | -725.67 Million CNY | -73.25% |
| 2022 Q3 | -418.84 Million CNY | -33.0% |
| 2021 FY | -1.03 Billion CNY | -1.52% |
| 2021 Q4 | -1.03 Billion CNY | -551.07% |
| 2021 Q1 | -171.4 Million CNY | 83.12% |
| 2021 Q2 | -246.42 Million CNY | -43.77% |
| 2021 Q3 | -158.3 Million CNY | 35.76% |
| 2020 Q2 | -360.8 Million CNY | -189.3% |
| 2020 FY | -1.01 Billion CNY | -154.22% |
| 2020 Q3 | -1.37 Billion CNY | -280.47% |
| 2020 Q4 | -1.01 Billion CNY | 26.04% |
| 2020 Q1 | 404.05 Million CNY | 201.18% |
| 2019 Q1 | 364.78 Million CNY | 0.0% |
| 2019 FY | -399.36 Million CNY | -9.48% |
| 2019 Q4 | -399.36 Million CNY | 0.0% |
| 2018 FY | -364.78 Million CNY | -33.73% |
| 2017 FY | -272.76 Million CNY | -20.14% |
| 2016 Q2 | -77.94 Million CNY | 0.0% |
| 2016 Q1 | -77.94 Million CNY | -14.58% |
| 2016 FY | -227.03 Million CNY | -233.74% |
| 2015 Q4 | -68.02 Million CNY | 0.0% |
| 2015 Q1 | 50.24 Million CNY | 0.0% |
| 2015 FY | -68.02 Million CNY | -160.98% |
| 2014 FY | -26.06 Million CNY | -333.6% |
| 2013 FY | 11.15 Million CNY | 0.0% |